Only a small percentage of older adults with early Alzheimer’s eligible for new treatments

Only a small percentage of older adults who are in the early stages of Alzheimer’s disease meet the eligibility criteria to receive new monoclonal antibody treatments, drugs that target amyloid-ß plaques in the brain, an early sign of Alzheimer’s disease.

Introducing the Psychedelic News Feed – Psychedelic Alpha

I’m excited to share our latest free feature: The Psychedelic News Feed. This webpage aims to serve as a one-stop destination for the latest media

October 31, 2023

Relay Therapeutics points to drug price negotiations for delay in potential blockbuster cancer drug

While it may ultimately be impossible to verify why exactly a clinical-stage biotech would delay a potential new drug approval, Relay Therapeutics said yesterday that

October 14, 2023

Evonetix unveils new branding to align with its vision for gene-length DNA synthesis

EVONETIX LTD (‘Evonetix’) today announces the introduction of new branding.

October 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.